| Mrs Rachel Fields, AGACNP-BC | |
|
424 Savannah Rd, Lewes, DE 19958-1462 | |
| (302) 645-3300 | |
| Not Available |
| Full Name | Mrs Rachel Fields |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Acute Care |
| Location | 424 Savannah Rd, Lewes, Delaware |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336535715 | NPI | - | NPPES |
| Entity Name | Beebe Physician Network Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730133992 PECOS PAC ID: 5496744864 Enrollment ID: O20040511000133 |
News Archive
Learning-related brain activity in Parkinson's patients improves as much in response to a placebo treatment as to real medication, according to a new study by researchers at the University of Colorado Boulder and Columbia University.
The U.S. Food and Drug Administration today approved Perjeta (pertuzumab), a new anti-HER2 therapy, to treat patients with HER2-positive late-stage (metastatic) breast cancer.
Experts say that fighting maternal mortality will cost the world a total of $24 billion annually, or an additional $12 billion per year, the Toronto Star writes in an article about Canada's G8 maternal and child health initiative and a maternal health conference that is being planned ahead of the G8 meeting.
A first-in-human, Phase 1 trial assessing the safety and immunogenicity of an investigational nanoparticle influenza vaccine designed to provide long-lasting protection against multiple flu virus strains has begun at the National Institutes of Health Clinical Center in Bethesda, Maryland.
› Verified 3 days ago
| Entity Name | Bayhealth Medical Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1023006434 PECOS PAC ID: 1658364740 Enrollment ID: O20160527000094 |
News Archive
Learning-related brain activity in Parkinson's patients improves as much in response to a placebo treatment as to real medication, according to a new study by researchers at the University of Colorado Boulder and Columbia University.
The U.S. Food and Drug Administration today approved Perjeta (pertuzumab), a new anti-HER2 therapy, to treat patients with HER2-positive late-stage (metastatic) breast cancer.
Experts say that fighting maternal mortality will cost the world a total of $24 billion annually, or an additional $12 billion per year, the Toronto Star writes in an article about Canada's G8 maternal and child health initiative and a maternal health conference that is being planned ahead of the G8 meeting.
A first-in-human, Phase 1 trial assessing the safety and immunogenicity of an investigational nanoparticle influenza vaccine designed to provide long-lasting protection against multiple flu virus strains has begun at the National Institutes of Health Clinical Center in Bethesda, Maryland.
› Verified 3 days ago
| Entity Name | Bayhealth Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073012696 PECOS PAC ID: 7719240696 Enrollment ID: O20180405000978 |
News Archive
Learning-related brain activity in Parkinson's patients improves as much in response to a placebo treatment as to real medication, according to a new study by researchers at the University of Colorado Boulder and Columbia University.
The U.S. Food and Drug Administration today approved Perjeta (pertuzumab), a new anti-HER2 therapy, to treat patients with HER2-positive late-stage (metastatic) breast cancer.
Experts say that fighting maternal mortality will cost the world a total of $24 billion annually, or an additional $12 billion per year, the Toronto Star writes in an article about Canada's G8 maternal and child health initiative and a maternal health conference that is being planned ahead of the G8 meeting.
A first-in-human, Phase 1 trial assessing the safety and immunogenicity of an investigational nanoparticle influenza vaccine designed to provide long-lasting protection against multiple flu virus strains has begun at the National Institutes of Health Clinical Center in Bethesda, Maryland.
› Verified 3 days ago
| Entity Name | Bayhealth Medical Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679072144 PECOS PAC ID: 1658364740 Enrollment ID: O20180411000470 |
News Archive
Learning-related brain activity in Parkinson's patients improves as much in response to a placebo treatment as to real medication, according to a new study by researchers at the University of Colorado Boulder and Columbia University.
The U.S. Food and Drug Administration today approved Perjeta (pertuzumab), a new anti-HER2 therapy, to treat patients with HER2-positive late-stage (metastatic) breast cancer.
Experts say that fighting maternal mortality will cost the world a total of $24 billion annually, or an additional $12 billion per year, the Toronto Star writes in an article about Canada's G8 maternal and child health initiative and a maternal health conference that is being planned ahead of the G8 meeting.
A first-in-human, Phase 1 trial assessing the safety and immunogenicity of an investigational nanoparticle influenza vaccine designed to provide long-lasting protection against multiple flu virus strains has begun at the National Institutes of Health Clinical Center in Bethesda, Maryland.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Rachel Fields, AGACNP-BC 34453 King Street Row, Lewes, DE 19958-4787 Ph: (302) 644-7676 | Mrs Rachel Fields, AGACNP-BC 424 Savannah Rd, Lewes, DE 19958-1462 Ph: (302) 645-3300 |
News Archive
Learning-related brain activity in Parkinson's patients improves as much in response to a placebo treatment as to real medication, according to a new study by researchers at the University of Colorado Boulder and Columbia University.
The U.S. Food and Drug Administration today approved Perjeta (pertuzumab), a new anti-HER2 therapy, to treat patients with HER2-positive late-stage (metastatic) breast cancer.
Experts say that fighting maternal mortality will cost the world a total of $24 billion annually, or an additional $12 billion per year, the Toronto Star writes in an article about Canada's G8 maternal and child health initiative and a maternal health conference that is being planned ahead of the G8 meeting.
A first-in-human, Phase 1 trial assessing the safety and immunogenicity of an investigational nanoparticle influenza vaccine designed to provide long-lasting protection against multiple flu virus strains has begun at the National Institutes of Health Clinical Center in Bethesda, Maryland.
› Verified 3 days ago
Ms. Helen A Merrick, APRN, BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 20251 John J Williams Hwy, Lewes, DE 19958 Phone: 302-644-6860 Fax: 302-644-6872 | |
Kimberly Beddow, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 424 Savannah Rd, Lewes, DE 19958 Phone: 302-645-3300 | |
Dr. Kiernan Elsa Quay, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 424 Savannah Rd, Lewes, DE 19958 Phone: 302-645-3300 | |
Vanessa Adams, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 400 Savannah Rd, Suite B, Lewes, DE 19958 Phone: 302-645-3555 Fax: 302-644-3560 | |
Mrs. Jennifer Willey, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 20268 Plantations Rd, Lewes, DE 19958 Phone: 302-644-2633 | |
Shelby Lynn Hogan, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 16392 Coastal Hwy, Lewes, DE 19958 Phone: 302-703-9743 | |
Taylor Hodges, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 16392 Coastal Hwy # 1, Lewes, DE 19958 Phone: 302-703-9743 |